In some countries, this medicine may only be approved for veterinary use.
In the US, Vinblastine (vinblastine systemic) is a member of the drug class mitotic inhibitors and is used to treat Breast Cancer, Cancer, Choriocarcinoma, Histiocytosis, Hodgkin's Lymphoma, Kaposi's Sarcoma, Lymphoma, Mycosis Fungoides and Testicular Cancer.
US matches:
- Vinblastine
- Vinblastine Intravenous
- Vinblastine Sulfate
UK matches:
- Vinblastine Sulphate 1 mg/ml Injection (SPC)
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
L01CA01
CAS registry number (Chemical Abstracts Service)
0000865-21-4
Chemical Formula
C46-H58-N4-O9
Molecular Weight
811
Therapeutic Category
Antineoplastic agent, microtubule inhibitor
Chemical Name
Vincaleukoblastine
Foreign Names
- Vinblastinum (Latin)
- Vinblastin (German)
- Vinblastine (French)
- Vinblastina (Spanish)
Generic Names
- Vinblastina (OS: DCIT)
- Vinblastine (OS: BAN, DCF)
- Vincaleukoblastin (IS)
- Vinblastine Sulfate (OS: USAN, JAN)
- Vinblastine Sulphate (OS: BANM)
- LE-29060 (IS)
- NSC 49842 (IS)
- Vincaleukoblastine Sulfate (IS)
- VLB (IS)
- Vinblastine (sulfate de) (PH: Ph. Eur. 6)
- Vinblastine Sulfate (PH: Ph. Int. 4, USP 32, JP XIV)
- Vinblastine Sulphate (PH: BP 2010, Ph. Eur. 6)
- Vinblastini sulfas (PH: Ph. Int. 4, Ph. Eur. 6)
- Vinblastinsulfat (PH: Ph. Eur. 6)
Brand Names
- Oncoblastin
Biotoscana, Colombia
- Velbastin
Korea United Pharm, Georgia
- Vinblastin Richter
Gedeon Richter, Bangladesh
- Vinblastina
Pharmachemie, Peru
- Vinblastine
Gedeon Richter, Tunisia
- Blastivin
Pharmachemie, Netherlands
- Blastovin
Teva, Argentina; Teva, Israel
- Cytoblastin
Cemelog-BRS, Bulgaria; Cipla, India; Cipla, Vietnam
- Exal
Nippon Kayaku, Japan
- Lemblastine
Chile, Chile
- Velbe
Crinos, Italy; Eurogenerics, Luxembourg; Genus, United Kingdom; Lilly, Greece; Lilly, Israel; Lilly, Kenya; Lilly, Nigeria; Lilly, Peru; Lilly, Romania; Lilly, Serbia; Lilly, Tanzania; Lilly, Uganda; Pharmacodane, Denmark; Stada, Austria; Stada, Sweden; Teva Pharma, Switzerland
- Velbé
EG Labo, France
- Velbe (veterinary use)
Clonmel, Ireland
- Vinblasin
Teva, Belgium
- Vinblastin Richter
Gedeon Richter, Czech Republic; Gedeon Richter, Georgia; Gedeon Richter, Russian Federation; Richter Gedeon RT, Slovakia
- Vinblastin Teva
Teva, Czech Republic
- Vinblastin
Gedeon Richter, Hungary; Gedeon Richter, Poland; Gedeon Richter, Serbia; Gedeon Richter, Russian Federation
- Vinblastina Ciclum Farma
Stada, Spain
- Vinblastina Filaxis
Filaxis, Argentina
- Vinblastina Lemblastine
World Pharma, Peru
- Vinblastina Martian
LKM, Argentina
- Vinblastina Mayne
Mayne, Spain
- Vinblastina Sulfato
Pharmaceutical, Venezuela
- Vinblastina
Biotoscana, Chile
- Vinblastine Injection DBL
Hospira, Australia
- Vinblastine PCH
Combiphar, Indonesia; Pharmachemie, Indonesia; Pharmachemie, South Africa
- Vinblastine Sulfate
APP, United States; Bedford, United States; Hospira, Canada; Hospira, Singapore; Hospira, Taiwan; Pharmachemie, Taiwan
- Vinblastine Sulphate DBL
Hospira, Indonesia; Mayne, Hong Kong; Tempo Scan Pacific, Indonesia
- Vinblastine Teva
Teva, Lithuania; Teva, Luxembourg; Teva, Latvia
- Vinblastine
Hospira, United Kingdom; Hospira, New Zealand; Mayne, Ireland
- Vinblastinsulfat-Gry
Teva-Gry, Germany
- Vincristine-Richter
Gedeon Richter, Russian Federation
- Xintoprost
Richmond, Argentina
International Drug Name Search
Glossary
BAN | British Approved Name |
BANM | British Approved Name (Modified) |
DCF | Dénomination Commune Française |
DCIT | Denominazione Comune Italiana |
IS | Inofficial Synonym |
JAN | Japanese Accepted Name |
OS | Official Synonym |
PH | Pharmacopoeia Name |
Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
SPC | Summary of Product Characteristics (UK) |
USAN | United States Adopted Name |
Click for further information on drug naming conventions and
International Nonproprietary Names.